Puma Biotechnology (PBYI) Return on Assets [ROA] (2011 - 2026)
Puma Biotechnology (PBYI) recorded Return on Assets [ROA] of 16.17% in Q2 2026, down 5.30 percentage points from 21.47% a year earlier but up 1.95 percentage points from the prior quarter.
Powered by 
Analysis
Puma Biotechnology (PBYI) Return on Assets [ROA] (2011 - 2026) Analysis & Trends
For FY2025, Puma Biotechnology reported Return on Assets [ROA] of 16.66%, up 5.80 percentage points from FY2024.
- Annual Return on Assets [ROA] has increased for eight straight years, with a five-year change of +41.70 percentage points (FY2020 to FY2025).
- Across earlier years, Return on Assets [ROA] came in at 10.86% in FY2024 (+1.32 pp), 9.54% in FY2023 (+9.54 pp), 0.00% in FY2022 (+12.37 pp) and -12.37% in FY2021 (+12.67 pp).
- Quarterly Return on Assets [ROA] has ranged from -22.92% in Q1 2022 to 21.47% in Q2 2025 over the past five years.
- On a year-over-year basis, Return on Assets [ROA] rose in six of the last eight quarters, with an average year-over-year change of +5.02 percentage points.
- Peak year-over-year performance for Return on Assets [ROA] in the last five years was a gain of 25.21 percentage points in Q1 2023, against a drop of 12.36 percentage points in Q1 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at 14.22% (Q1 2026), 17.07% (Q4 2025) and 15.54% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 19.00% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 8.08% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 7.32% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 1.87% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 9.36% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 9.80% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -7.67% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 2.00% |
| 10 | Puma Biotechnology | 420.82 Mn | 19.27 Mn | 39.86 Mn | 14.73% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 14.73% |
| Jun 30, 2026 | 16.80% |
| Mar 31, 2026 | 14.94% |
| Dec 31, 2025 | 17.75% |
| Sep 30, 2025 | 16.94% |
| Jun 30, 2025 | 22.69% |
| Mar 31, 2025 | 16.30% |
| Dec 31, 2024 | 11.52% |
| Sep 30, 2024 | 10.92% |
| Jun 30, 2024 | 4.16% |
| Mar 31, 2024 | 6.92% |
| Dec 31, 2023 | 9.95% |
| Sep 30, 2023 | 1.84% |
| Jun 30, 2023 | -1.23% |
| Mar 31, 2023 | 2.30% |
| Dec 31, 2022 | 0.00% |
| Sep 30, 2022 | 5.01% |
| Jun 30, 2022 | -17.49% |
| Mar 31, 2022 | -22.92% |
| Dec 31, 2021 | -12.82% |
API Access
Puma Biotechnology Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=PBYI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "PBYI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=PBYI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();